Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acquired immunodeficiency syndrome dementia complex
acquired immunodeficiency syndrome, older adults
activated protein C resistance
aducanumab
advance directives
advances in neurology
adverse drug reaction
aerobic exercise
age associated memory impairment
aggression
agitation
algorithm
aluminum
Alzheimer's disease
Alzheimer's disease, conjugal
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early onset
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, familial, late onset
Alzheimer's disease, incidence
Alzheimer's disease, misdiagnosis
Alzheimer's disease, pathogenesis
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, rapidly progressive
Alzheimer's disease, rate of clinical decline
Alzheimer's disease, risk factors in
Alzheimer's disease, treating associated medical problems in
Alzheimer's disease, treatment of
amnesia
amyloid
amyloid beta protein
amyloid beta protein antibodies
amyloid deposition
amyloid imaging
amyloid plaques
amyloidosis
amyloid-related imaging abnormalities
amyotrophic lateral sclerosis
anatomy of
angiotensin II receptor blocker
anti-amyloid therapy
anticoagulant, treatment
anticonvulsants
antihypertensive
antiphospholipid antibodies
antithrombin III deficiency
anxiety
apolipoprotein E
apoliprotein E, plasma level
APP
APP gene
asymptomatic
atrial fibrillation
atypical
automobile accidents
autonomic dysfunction
behavioral disorder
benzodiazepine
biologic markers
blacks
blood pressure
blood transfusion
bone density
carcinoma
caregiver
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral edema
cerebral edema, vasogenic
cerebral infarction
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, familial occurrence
cerebrovascular accident, infancy and childhood
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
children
chromosomal abnormality
chromosome 12
cigarette smoking
clinical trials
cognition
comorbidities
complications
confusion
contraindications
controversies in neurology
cost
coumarin
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, diagnostic evaluation of
dementia, differential diagnosis of
dementia, driving with
dementia, early detection
dementia, familial
dementia, incidence
dementia, prevalence of
dementia, prevention of
dementia, rapidly progressive
dementia, screening for
dementia, treatment of
depression
diabetes mellitus
diagnostic criteria
disease modifying agents
dizziness
donanemab
donepezil
driving
drug abuse
dural sinus thrombosis
educational status
efficacy
electromagnetic fields
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
familial
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
fibrinolytic agents, utilization
fracture, long bone
gadolinium
gantenerumab
gender
gene
genetic counselling
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
glaucoma
haloperidol
head injury
headache
hemiparesis
hemosiderosis of CNS, superficial
heralding manifestation
herpes simplex virus
hip fracture
hippocampal atrophy
hippocampus
Hispanics
homocysteine, serum
homosexual
hormone replacement
hormone therapy
human immunodeficiency virus type 1
hydrocephalus
hypercholesterolemia
hyperhomocysteinemia
hyperinsulinism
hypertension
hypoxia
iatrogenic neurologic disorders
incidence
intellectual deficit
intellectual deterioration
intracerebral hemorrhage
intracranial pressure, increased
inverse association
Jakob-Creutzfeldt disease
lecanemab
leisure activity
level of consciousness, decreased
lifestyle
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lipid lowering agent
managed care
marital status
medical-legal aspects of neurology
memory
memory, defect of recent
memory, evaluation of
memory, impairment of
memory, impairment of, isolated
memory, impairment of, subjective
meningitis
menopause
mental activity
mental status, abnormal
mesial temporal lobe
microhemorrhage, intracerebral
middle cerebral artery territory infarction
middle cerebral artery, occlusion of
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
mimics
Mini Mental Status Examination
misdiagnosis
molecular genetics
mongolism
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, functional
MRI, venography
multiple sclerosis
myoclonus
negative
nerve growth factor
neurofibrillary degeneration
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic consultation
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination, focal
neurologic signs
neurologic symptoms
neuropathology
neuropathy
neuroprotective agents
nicotine
nonsteroidal anti-inflammatory drug
normal
occupational neurologic disorders
old age, driving and
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
osteoporosis
Parkinson disease
Parkinson disease, etiology of
patient information and support
pitfalls
Pittsburgh Compound B
placebo
polysomnogram
practice guidelines
preclinical
pregnancy, neurologic complications in
premarin
presenilin-1 gene
presenilin-2 gene
prethrombotic state
prevention of neurologic disorders
progesterone
prognosis
protein C deficiency
protein S deficiency
proteinopathy
psychological testing
psychotic behavior
remternetug
research
review article
rhinorrhea, CSF
risk factors
risk factors, modification
risk-benefit assessment
risperidone
rosacea
safety
screening
seizure
seizure, elderly
seizure, focal
seizure, risk factors for
selective serotonin reuptake inhibitors
senile plaques
shared decision making
sildenafil
skin, lesions in neurologic disorders
sleep
sleep pathology and physiology
smell
Smell Identification Test
sodium-glucoe cotransporter-2 inhibitors
straight sinus
stress, emotional
superior sagittal sinus thrombosis
tau protein
TDP-43 proteinopathy
temporal lobe, atrophy
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
treatment of neurologic disorder
TREM2 variants
water, drinking
weight loss
white matter disease
whites
workup
Showing articles 450 to 500 of 7284 << Previous Next >>

Primary Prevention of Stroke
JAMA 316:658-659, Steiger, N. & Cifu, A.S., 2016

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
NEJM 375:1131-1141,1185, Connolly, S.J.,et al, 2016

Global and Regional Effects of Potentially Modifiable Risk Factors Associated with Acute Stroke in 32 Countries (INTERSTROKE): A Case-Control Study
Lancet 388:761-775,733, ODonnell M.J.,et al, 2016

Diagnosis and Treatment of Tourette Syndrome
Neurol 87:e65-e67, Hirschtritt, M.E.,et al, 2016

Review of the Utility of Prophylactic Anticonvulsant Use in Critically Ill Patients with Intracerebral Hemorrhage
Stroke 47:2666-2672, Gilmore, E.J.,et al, 2016

Mycoplasma Pneumoniae Triggering the Guillain-Barre Syndrome
Ann Neurol 80:566-580, Meyer Sauteur, P.M.,et al, 2016

Clinical Relevance of Microbleeds in Acute Stroke Thrombolysis
Neurol 87:1534-1541, Charidimou, A.,et al, 2016

Short Time Interval Between Neurologic Event and Carotid Surgery is Not Associated with an Increased Procedural Risk
Stroke 47:2783-2790, Tsantilas, P.,et al, 2016

Stroke Risk and Mortality in Patients with Ventricular Assist Devices
Stroke 47:2702-2706,2677, Parikh, N.S.,et al, 2016

Emerging Risk Factors for Recurrent Vascular Events in Patients with Embolic Stroke of Unertermined Source
Stroke 47:2714-2721, Ueno, Y.,et al, 2016

Early Start of DOAC after Ischemic Stroke
Neurol 87:1856-1862,1652, Seiffge, D.J.,et al, 2016

Cortical Superficial Siderosis Predicts Early Recurrent Lobar Hemorrhage
Neurol 87:1863-1870,1854, Roongpiboonsopit, D.,et al, 2016

Thrombus Histology Suggests Cardioembolic Cause in Cryptogenic Stroke
Stroke 47:1864-1871, Boeckh-Behrens, T.,et al, 2016

Histologic Analysis of Retrieved Clots in Acute Ischemic Stroke: Correlation with Stroke Etiology and Gradient-Echo MRI
AJNR 36:1756-1762, Kim, S.K.,et al, 2016

Should Atrial Fibrillation Patients with only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
Stroke 47:1831-1836, Fauchier, L.,et al, 2016

Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage
Stroke 47:1837-1843, Ottosen, T.P.,et al, 2016

Postmenopausal Hormone Therapy and Risk of Stroke
Stroke 47:1734-1741, Canonico, M.,et al, 2016

Advanced Interatrial Block and Ischemic Stroke
Neurol 87:352-356, ONeal, W.T.,et al, 2016

Outcomes with Edoxaban Versus Warfarin in Patients with Previous Cerebrovascular Events
Stroke 47:2075-2082, Rost, N.S.,et al, 2016

Pathogenesis and Risk Factors for Cerebral Infarct After Surgical Aortic Valve REplacement
Stroke 47:2130-2132, Massor, Al.,et al, 2016

Managing Risk After Intracerebral Hemorrhage in Concomitant Atrial Fibrillation and Cerebral Amyloid Angiopathy
Stroke 47:e190-e192, Stoker, T.B.,et al, 2016

Clinopathologic Conference, Celiac Disease
NEJM 374:1875-1883, Case 14-2016, 2016

Risk of Cerebral Venous Thrombosis in Obese Women
JAMA Neurol 73:579-584, Zuurbier, S.M.,et al, 2016

Exploring the Association Between Rosacea and Parkinson Disease
JAMA Neurol 73:529-534, Egeberg, A.,et al, 2016

Which Oral Anticoagulation for Atrial Fibrillation?
JAMA 315:2117-2118, The Medical Letter, 2016

Aortic Dissections Type A during Sexual Intercourse in Male Patients: Accident or Systematic Coincidence? Examination of 365 Patients with Acute Aortic Dissection within 20 Years
Thorac Cardiovasc Surg 64:133-136, Gansera, L.,et al, 2016

Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016

Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016

Risk of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and High Cerebral Microbleed Burden
JAMA Neurol 73:675-683,632, Tsivgoulis, G.,et al, 2016

Carotid Near-Occlusion: A Comprehensive Review, Part 2- Prognosis and Treatment, Pathophysiology, Confusions, and Areas for Improvement
AJNR 37:200-204, Johansson, E. & Fox, A.J., 2016

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
NEJM 374: DOI:10.1056/NEJMoa1506930, Kernan, W.N.,et al, 2016

Silent Brain Infarction and Risk of Future Stroke
Stroke 47:719-725, Gupta, A.,et al, 2016

Infective Endocarditis
Lancet 387:882-893, Cahill, T.J. & Prendergast, B.D., 2016

Clinical Manifestations and Evaluation of Adults with Suspected Native Valve Endocarditis
UpToDate Feb, Sexton, D.J. & Fowler,Jr., V.G., 2016

Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
Front Neurol 7:1-16, Nouh, A.,et al, 2016

Association Between Age and Risk of Stroke or Death from Carotid Endarterectomy and Carotid Stenting: A Meta-Analysis of Pooled Patient Data from Four Randomised Trials
Lancet 387:1305-1311, Howard, G.,et al, 2016

Cocaine Use and Risk of Ischemic Stroke in Young Adults
Stroke 47:918-922, Cheng, Y.C.,et al, 2016

Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 47:1127-1130, Purrucker, J.C.,et al, 2016

Stroke in Commercial Flights
Stroke 47:1117-1119, Alvarez-Velasco, R.,et al, 2016

Stroke as the Initial Manifestation of the Human Immunodeficiency Virus
Stroke 47:e60-e62, Manwani, B.,et al, 2016

Metronidazole-Associated Encephalopathy
NEJM 374:1465, Baden, L.R., 2016

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
NEJM 374:1533-1542,1577, Amarenco, P.,et al, 2016

Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort
Neurol 86:1683-1691,1655, Lee, W.J.,et al, 2016

Prognosis of Asymptomatic Carotid Artery Occlusion
Stroke 47:1253-1257, Hackam, D.G.,et al, 2016

Retinal Artery Occlusion and the Risk of Stroke Development
Stroke 47:376-382, Hyungtaek, T.,et al, 2016

Tranexamic Acid-Associated Seizures: Causes and Treatment
Ann Neurol 79:18-26, Lecker, I.,et al, 2016

Natalizumab-Related PML 2 Weeks after Negative Anti-JCV Antibody Assay
Neurol 86:484-486, Gagne, M.S.,et al, 2016

Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
JAMA Neurol 73:169-177,155, Purrucker, J.C.,et al, 2016

Myasthenia Gravis after Botulinum Toxin Type A Injection
Turk J Neurol 22:143-144, Tekce, H.D.,et al, 2016

Idiopathic Thoracic Spontaneous Spinal Epidural Hematoma
Case Reports Surg doi:10.1155/2016/5430708, Aycan, A.,et al, 2016



Showing articles 450 to 500 of 7284 << Previous Next >>